NewsLinks is a collection of recent news items relating primarily to the California judicial branch. NewsLinks does not verify or endorse the accuracy or fairness of the news items, and the views expressed in opinions, editorials, and commentaries are those of the writers only. Some news articles linked from this page may require a subscription or be behind a paywall.

NewsLinks

  • Commission to Act on C.A. Nominations

    Metropolitan News-Enterprise
    August 6, 2026

    Members of the Commission on Judicial Appointments will meet today in San Francisco to consider the nomination of Court of Appeal Associate Justice Tari Cody of this district’s Court of Appeal Div. Six as presiding justice of the Ventura-based panel on which she now sits and the proposed elevation of Los Angeles Superior Court Judge Nicholas Daum as a justice of this district’s Div. Four.

  • Riverside County seized ballots case goes to California Supreme Court

    The Press-Enterprise
    August 6, 2026

    The California Supreme Court has scheduled oral arguments for Monday, Aug. 24, in two cases stemming from the sheriff’s seizure earlier this year of ballots cast by Riverside County voters in November’s Proposition 50 special election, which redrew the state’s congressional districts to favor Democrats.

  • California Nears Becoming First to Set Attorney AI Guardrails

    Bloomberg Law
    August 6, 2026

    (Subscription required) California legislators are nearing the final steps to create a first-in-the-nation law for the legal industry, establishing ethical expectations and guardrails for lawyers and arbitrators in the state on the use of generative artificial intelligence.

  • California High Court’s Gilead Ruling Marks Tort Law Sea Change

    Bloomberg Law
    August 5, 2026

    In its ruling, the California high court’s majority cited its precedent in Rowland v. Christian, saying that foreseeability and policy considerations may justify an exception if the court assumes that Gilead had a duty of care beyond its responsibility to design and manufacture safe drugs.

    Related: Lawyer Monthly